2017-17961. Determination of Regulatory Review Period for Purposes of Patent Extension; RECUVYRA; Affirmation
-
Start Preamble
Start Printed Page 40008
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notification of affirmation.
DATES:
August 23, 2017
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Joyce Strong, Office of Policy, 10903 New Hampshire Ave., Bldg. 51, Silver Spring, MD 20993, 301-796-9148.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The Food and Drug Administration (FDA) is affirming the signature date for a notice that appeared in the Federal Register on August 21, 2017 (82 FR 39587). The document announced FDA's determination for the regulatory review period for RECUVYRA. The document published with an incorrect date for the signature. We affirm that the document was signed on August 15, 2017.
Start SignatureEnd Signature End Supplemental InformationDated: August 21, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017-17961 Filed 8-21-17; 4:15 pm]
BILLING CODE 4164-01-P
Document Information
- Published:
- 08/23/2017
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notification of affirmation.
- Document Number:
- 2017-17961
- Dates:
- August 23, 2017
- Pages:
- 40008-40008 (1 pages)
- Docket Numbers:
- Docket Nos. FDA-2013-E-0264, FDA-2013-E-0263, and FDA-2013-E-0218
- PDF File:
- 2017-17961.pdf